Company / Current Liabilities
ENDRA Life Sciences Inc. Current Liabilities History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$986.7K
FY2020
5-year range
$848.2K / $2.1M
FY2017-FY2020
Trend
-52.4%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$986,663 in FY2020 with a 3-year CAGR of +5.2%.
Remained stable around $986,663 over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +5.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +5.2%, indicating consistent growth.
- In FY2020, current liabilities decreased 52.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $986.7K | -52.4% |
| FY2019 | $2.1M | +112.7% |
| FY2018 | $974.6K | +14.9% |
| FY2017 | $848.2K | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026